MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Phase 2
Terminated
Conditions
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Target Recruit Count
29
Registration Number
NCT00004106
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Recruiting
Conditions
Endometrial Cancer
Sarcoma
Vulvar Cancer
Cervical Cancer
Fallopian Tube Cancer
Ovarian Cancer
Uterine Leiomyomata
Hereditary Breast/Ovarian Cancer (brca1, brca2)
Vaginal Cancer
Interventions
Other: Ca-125
Other: screening questionnaire administration
Procedure: Surgery
First Posted Date
2003-01-27
Last Posted Date
2025-02-28
Lead Sponsor
Northwestern University
Target Recruit Count
6000
Registration Number
NCT00005095
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

Completed
Conditions
Breast Cancer
Osteoporosis
First Posted Date
2003-01-27
Last Posted Date
2011-02-21
Lead Sponsor
Northwestern University
Target Recruit Count
79
Registration Number
NCT00005605
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Phase 2
Completed
Conditions
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Leukemia
First Posted Date
2003-01-27
Last Posted Date
2012-06-12
Lead Sponsor
Northwestern University
Registration Number
NCT00004896
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Phase 2
Terminated
Conditions
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00005788
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1
Terminated
Conditions
Neutropenia
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2012-06-01
Lead Sponsor
Northwestern University
Target Recruit Count
3
Registration Number
NCT00005787
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Total Parenteral Nutrition-Associated Liver Disease

Phase 2
Terminated
Conditions
Liver Diseases
First Posted Date
2002-02-27
Last Posted Date
2015-03-25
Lead Sponsor
Northwestern University
Target Recruit Count
48
Registration Number
NCT00031135
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Northwestern University
Target Recruit Count
100
Registration Number
NCT00002230
Locations
🇺🇸

Northwestern Univ Med School, Chicago, Illinois, United States

INTERMAP: International Population Study on Macronutrients and BP

Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
First Posted Date
2000-05-26
Last Posted Date
2016-01-12
Lead Sponsor
Northwestern University
Target Recruit Count
4680
Registration Number
NCT00005271

Prevention of Hypertension: A Randomized Trial

Phase 3
Completed
Conditions
Vascular Diseases
Hypertension
Cardiovascular Diseases
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2014-11-24
Lead Sponsor
Northwestern University
Registration Number
NCT00000495
© Copyright 2025. All Rights Reserved by MedPath